Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopes

References

• Allison AG, Gregoriadis G. Liposomes as immunological adjuvants. Nature 1974; 252: 252
   PubMed Web of Science ®Google Scholar
• Alving CR. Antibodies to lipids and liposomes: Immunology and safety. J Liposome Res 2006; 16: 157–166
   PubMed Web of Science ®Google Scholar
• Alving CR. 4E10 and 2F5 monoclonal antibodies: Binding specificities to phospholipids, tolerance, and clinical safety issues. AIDS 2008; 22: 649–651
   PubMed Web of Science ®Google Scholar
• Alving CR, Rao M. Lipid A and liposomes containing lipid A as antigens and adjuvants. Vaccine 2008; 26: 3036–3045
   PubMed Web of Science ®Google Scholar
• Alving CR, Wassef NM. Naturally occurring antibodies to cholesterol: A new theory of LDL cholesterol metabolism. Immunol Today 1999; 20(8)362–366
   PubMedGoogle Scholar
• Alving CR, Beck Z, Karasavva N, Matyas GR, Rao M. HIV-1, lipid rafts, and antibodies to liposomes: Implications for anti-viral-neutralizing antibodies. Mol Membr Biol 2006; 23(6)453–465
   PubMed Web of Science ®Google Scholar
• Beck Z, Karasavvas N, Tong J, Matyas GR, Rao M, Alving CR. Calcium modulation of monoclonal antibody binding to phosphatidylinositol phosphate. Biochem Biophys Res Commun 2007; 354(3)747–751
   PubMed Web of Science ®Google Scholar
• Binley JM, Wrin T, Korber B, Zwick MB, Wang M, Chappey C, Stiegler G, Kunert R, Zolla-Pazner S, Katinger H, Petropoulos CJ, Burton DR. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J Virol 2004; 78(23)13232–13252
   PubMed Web of Science ®Google Scholar
• Brown BK, Karasavvas N, Beck Z, Matyas GR, Birx DL, Polonis VR, Alving CR. Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: Role of phosphate-binding subsites. J Virol 2007; 81(4)2087–2091
   PubMed Web of Science ®Google Scholar
• Buchacher A, Predl R, Strutzenberger K, Steinfellner W, Trkola A, Purtscher M, Gruber G, Tauer C, Steindl F, Jungbauer A, Katinger H. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein–Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS Res Hum Retroviruses 1994; 10(4)359–369
   PubMed Web of Science ®Google Scholar
• Burton DR, Desrosiers RC, Doms RW, Koff WC, Kwong PD, Moore JP, Nabel GJ, Sodroski J, Wilson IA, Wyatt RT. HIV vaccine design and the neutralizing antibody problem. Nat Immunol 2004; 5(3)233–236
   PubMed Web of Science ®Google Scholar
• Fries LF, Gordon DM, Richards RL, Egan JE, Hollingdale MR, Gross M, Silverman C, Alving CR. Liposomal malaria vaccine in humans: A safe and potent adjuvant strategy. Proc Natl Acad Sci U S A 1992; 89(1)358–362
   PubMed Web of Science ®Google Scholar
• Galfrè G, Milstein C. Preparation of monoclonal antibodies: Strategies and procedures. Methods Enzymol 1981; 73: 3–46
   PubMedGoogle Scholar
• Garçon N, Chomez P, Van Mechelen M. GlaxoSmithKline Adjuvant Systems in vaccines: Concepts, achievements and perspectives. Expert Rev Vaccines 2007; 6(5)723–739
   PubMed Web of Science ®Google Scholar
• Haynes BF, Fleming J, Clair EW, Katinger H, Stiegler G, Kunert R, Robinson J, Scearce RM, Plonk K, Staats HF, Ortel TL, Liao HX, Alam SM. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 2005; 308(5730)1906–1908
   PubMed Web of Science ®Google Scholar
• Haynes BF, Alam SM. HIV-1 hides an Achilles’ heel in virion lipids. Immunity 2008; 28(1)10–12
   PubMed Web of Science ®Google Scholar
• Karasavvas N, Beck Z, Tong J, Matyas GR, Rao M, McCutchan FE, Michael NL, Alving CR. Antibodies induced by liposomal protein exhibit dual binding to protein and lipid epitopes. Biochem Biophys Res Commun 2008; 366(4)982–987
   PubMed Web of Science ®Google Scholar
• Kumar A, Arora R, Kaur P, Chauhan VS, Sharma P. “Universal” T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide. J Immunol 1992; 148(5)1499–1505
   PubMed Web of Science ®Google Scholar
• Kundi M. New hepatitis B vaccine formulated with an improved adjuvant system. Expert Rev Vaccines 2007; 6(2)133–140
   PubMed Web of Science ®Google Scholar
• Matyas GR, Wassef NM, Rao M, Alving CR. Induction and detection of antibodies to squalene. J Immunol Methods 2000; 245(1–2)1–14
   PubMed Web of Science ®Google Scholar
• Rao M, Matyas GR, Vancott TC, Birx DL, Alving CR. Immunostimulatory CpG motifs induce CTL responses to HIV type I oligomeric gp140 envelope protein. Immunol Cell Biol 2004; 82(5)523–530
   PubMed Web of Science ®Google Scholar
• Schuster BG, Neidig M, Alving BM, Alving CR. Production of antibodies against phosphocholine, phosphatidylcholine, sphingomyelin, and lipid A by injection of liposomes containing lipid A. J Immunol 1979; 122(3)900–905
   PubMed Web of Science ®Google Scholar
• Sun ZY, Oh KJ, Kim M, Yu J, Brusic V, Song L, Qiao Z, Wang JH, Wagner G, Reinherz EL. HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane. Immunity 2008; 28(1)52–63
   PubMed Web of Science ®Google Scholar
• Uemura K, Nicolotti RA, Six HR, Kinsky SC. Antibody formation in response to liposomal model membranes sensitized with N-substituted phosphatidylethanolamine derivatives. Biochemistry. 1974; 13(8)1572–1578
   PubMed Web of Science ®Google Scholar
• Vandepapelière P, Horsmans Y, Moris P, Van Mechelen M, Janssens M, Koutsoukos M, Van Belle P, Clement F, Hanon E, Wettendorff M, Garçon N, Leroux-Roels G. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. Vaccine 2008; 26(10)1375–1386
   PubMed Web of Science ®Google Scholar
• Wassef NM, Roerdink F, Swartz GM, Jr, Lyon JA, Berson BJ, Alving CR. Phosphate-binding specificities of monoclonal antibodies against phosphoinositides in liposomes. Mol Immunol 1984; 21(10)863–868
   PubMed Web of Science ®Google Scholar
• Wassef NM, Alving CR, Richards RL. Liposomes as carriers for vaccines. Immunomethods 1994; 4(3)217–222
   PubMedGoogle Scholar
• Zwick MB, Labrijn AF, Wang M, Spenlehauer C, Saphire EO, Binley JM, Moore JP, Stiegler G, Katinger H, Burton DR, Parren PW. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J Virol 2001; 75(22)10892–10905
   PubMed Web of Science ®Google Scholar